Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Sci-Tech Network.
Press releases published on October 21, 2025
Qinary Unveils Innovative AI Search Blueprint for Market Leadership
Scottsdale, Arizona, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Qinary, a pioneering force in next-generation marketing systems, is proud to announce a groundbreaking initiative led by its CEO, Buck Wise. This new venture is set to revolutionize how entrepreneurs …
Biomea Fusion to Participate in Citi's SMID Biotech C-Suite Fireside Chat Series
SAN CARLOS, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will participate in Citi’s SMID Biotech C-Suite Fireside Chat Series on Thursday, …
Rocket Doctor AI Engages Fundamental Research Corp. for Analyst Coverage
Vancouver, BC, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that we have engaged Fundamental Research Corp. (“FRC”), an independent small-cap research firm, for analyst …
DeLeion Capital Launches Innovative Digital Asset Management Plans for Bitcoin, Ethereum, and XRP
Washington, USA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- DeLeion Capital, a leading digital asset management company specializing in blockchain-based investment strategies, today announced the launch of its new suite of asset management plans designed for …
Enovix to Release Third Quarter 2025 Financial Results on November 5, 2025
FREMONT, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced it will release financial results for the third quarter on Wednesday, November 5, …
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
ROCKVILLE, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that …
IGEL and Asc3nd Collaborate with Cisco, the National Defense University1 to Accelerate DoW Comply-to-Connect and Zero Trust Mission Readiness
FORT LAUDERDALE, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- IGEL, the global leader in endpoint security and provider of the IGEL Secure Endpoint OS Platform™ for now and next, today announced the successful completion of a joint initiative in collaboration …
VDE Americas Goes Global to Meet Rising Demand for Hail Risk Intelligence
SAN JOSE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- VDE Americas, a global leader in technical advisory and catastrophic risk assessment services for the solar industry, today announced the internationalization of its innovative hail risk assessment and …
Teva und Prestige Biopharma schließen Lizenzvereinbarung für die Vermarktung von Tuznue® in Europa
Teva und Prestige geben eine Lizenz- und Liefervereinbarung für die Vermarktung des von Prestige hergestellten Arzneimittels Tuznue® bekannt, einem Biosimilar zu Herceptin® (trastuzumab) Die Europäische Kommission (EK) erteilte Tuznue® im September 2024 …
Teva et Prestige Biopharma concluent un accord de licence pour la commercialisation de Tuznue® en Europe
Teva et Prestige annoncent un accord de licence et d’approvisionnement pour la commercialisation de Tuznue®, un biosimilaire d’Herceptin® (trastuzumab) produit par Prestige Tuznue® a reçu l’autorisation de mise sur le marché de la Commission européenne (CE …
Pala Casino Spa Resort Successfully Upgrades to QCI’s Latest Enterprise Platform, AGI56
SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a global leader in AI-driven analytics and operational intelligence for casinos and resorts, announced today that Pala Casino Spa Resort has successfully completed its upgrade to …
DeLeion Capital Launches Ethereum Digital Asset Custody Service Amid Market Uncertainty — Offering a Secure Path
Florida City, Oct. 21, 2025 (GLOBE NEWSWIRE) -- In the wake of growing political and economic uncertainty in the United States, DeLeion Capital, a leading global digital asset management firm, has announced the official launch of its Ethereum (ETH) …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
AvePoint to Announce Third Quarter 2025 Financial Results on November 6
JERSEY CITY, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in data security, governance, and resilience, will report its third quarter 2025 financial results after the US financial markets close on Thursday, …
Inspired to Report Third Quarter 2025 Results and Hold Conference Call on November 5
NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inspired Entertainment, Inc. ("Inspired" or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, technology, hardware and services, announced that it will report financial results for the …
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
WOODCLIFF LAKE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the voting results for each of the matters presented at the Company’s 2025 annual meeting of stockholders …
Inotiv, Inc. to Participate in Three Investor Conferences in November 2025
WEST LAFAYETTE, Ind., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK
TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a biopharmaceutical company developing exosome-based regenerative therapies, announced that Dr. Ina …
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients …
Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will …